Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3JR, UK.
Hum Mol Genet. 2012 Sep 1;21(17):3806-14. doi: 10.1093/hmg/dds208. Epub 2012 May 31.
Rett Syndrome is a neurological disorder caused by mutations in the X-linked MECP2 gene. Mouse models where Mecp2 is inactivated or mutated recapitulate several features of the disorder and have demonstrated a requirement for the protein to ensure brain function in adult mice. We deleted the Mecp2 gene in ~80% of brain cells at three postnatal ages to determine whether the need for MeCP2 varies with age. Inactivation at all three time points induced Rett-like phenotypes and caused premature death of the animals. We find two threshold ages beyond which the requirement for MeCP2 markedly increases in stringency. The earlier threshold (8-14 weeks), when inactivated mice develop symptoms, represents early adulthood in the mouse and coincides with the period when Mecp2-null mice exhibit terminal symptoms. Unexpectedly, we identified a later age threshold (30-45 weeks) beyond which an 80% reduction in MeCP2 is incompatible with life. This finding suggests an enhanced role for MeCP2 in the aging brain.
雷特综合征是一种由 X 连锁 MECP2 基因突变引起的神经发育障碍。Mecp2 失活或突变的小鼠模型重现了该疾病的多种特征,并证明该蛋白在成年小鼠中确保大脑功能的必要性。我们在三个出生后年龄删除了约 80%的脑细胞中的 Mecp2 基因,以确定对 MeCP2 的需求是否随年龄而变化。在所有三个时间点的失活都会诱导雷特样表型,并导致动物过早死亡。我们发现有两个阈值年龄,超过这个年龄,对 MeCP2 的需求在严格程度上显著增加。较早的阈值(8-14 周),当失活的小鼠出现症状时,代表了小鼠的成年早期,与 Mecp2 缺失的小鼠出现终末期症状的时期相吻合。出乎意料的是,我们确定了一个较晚的年龄阈值(30-45 周),超过这个年龄,MeCP2 的减少 80%与生命不相容。这一发现表明 MeCP2 在衰老大脑中发挥了增强的作用。